HK Stock Market Move | HENLIUS (02696) rose nearly 4% as the commercialization of the targeted therapy drugs BILDYOS and TUZEMTY in Canada began.
Fosun Pharma (02696) rose nearly 4%, as of the time of writing, it rose by 3.98% to HK $65.05, with a turnover of HK $1050.57 million.
HENLIUS (02696) rose nearly 4% at the time of writing, up 3.98% to HK$65.05, with a turnover of HK$10.57 million.
On the news front, on June 23, according to HENLIUS official WeChat account, the company announced a commercial launch in Canada for Denosumab Injection (60 mg/mL) BILDYOS and Denosumab Injection (120 mg/1.7 mL) TUZEMTY, covering all approved indications of the original drugs PROLIA and XGEVA in Canada. Denosumab is used for various indications, enhancing bone strength for the treatment of osteoporosis and tumor-related bone events.
BILDYOS's launch in Canada further expands treatment options for Canadian patients and helps reduce healthcare costs by increasing access to biosimilars. These two products further enrich Organon's expanding portfolio of biosimilar products in Canada, covering five major therapeutic areas, including cancer, with several products on the market for over nine years.
Related Articles

HK Stock Market Move | Electricity stocks continue to decline, while coal prices have increased both month-on-month and year-on-year during this period. The net profit of thermal power companies in the second quarter may be under pressure compared to the same period last year.

HK Stock Market Move | Dongjiang Environmental (00895) fell by over 17%. The company stated that there have been no significant changes in its operations that should have been disclosed but were not disclosed.

New stock news | Shenzhen Forms Syntron Information (300468.SZ) Hong Kong IPO prospectus ineffective
HK Stock Market Move | Electricity stocks continue to decline, while coal prices have increased both month-on-month and year-on-year during this period. The net profit of thermal power companies in the second quarter may be under pressure compared to the same period last year.

HK Stock Market Move | Dongjiang Environmental (00895) fell by over 17%. The company stated that there have been no significant changes in its operations that should have been disclosed but were not disclosed.

New stock news | Shenzhen Forms Syntron Information (300468.SZ) Hong Kong IPO prospectus ineffective

RECOMMEND





